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Mathematical Modeling and Simulation of 
Latency Phase HIV-l Dynamics 
Frank Nani and Mingxian J in 
Department of Mathematics and Computer Science 
Fayetteville State University 
Fayettev ille, NC 28301 , USA 
Abstract - In this paper, the parho-physiological dynamics 
of HlV-/ induced AIDS is analyzed using Q system oj 
deterministic ordinary differential equations. The 
mathematical model exhibits explicitly the dynamics of the 
HlV-J virions during latency phase in the absence of 
anti-viral therapy. The model presented in this paper is a 
generalization of previous models of HlV-J dynamics and 
incorporales Ihe interactions between the HIV- J virions, 
infected helper T-Iymphocytes. uninfected helper 
r-Iymphocytes, and cytotoxic T-Iymphocytes, as well as 
COn/ributions to HIV-J reservoirs. Investigative compuler 
simulations using clinically plausible parametric 
configurations are presenled. Clinically relevant criteria 
are derived depicting the annihilation, cOn/rol, or 
persistence of HIV-J in Ihe absence of anli-virallherapy. 
Keywords: HIV-I dynam ics, mathematical modeling, 
model simulation 
1. Introduction 
The dynamics of HIV-I infection may be divided into 
three phases: the initial (pre-latency) phase called primary 
HI V- I infection; the latency phase, and the post Imency 
phase. During the pre-latency phase, the HI V- I virions 
present in the infecting inoculums replicate in the host 
(CD4+) T lymphocytes, producing a viremia wh ich elicits 
immune response due to viral antigen-presentation action by 
the monocytic phagocytic system (MPS) of macro phages. 
The initial infection leads to transient infection 
resembling mononucleosis for 1-1 2 weeks after exposure 
[2,3]. Although symptomatic primary HI V-l infection is 
usually characterized by fever, lymphadenopathy, 
pharyngitis, arthralgia, rash, and lethargy, many infected 
ind ividuals have no such acute phase of HIV infection. 
Studies have shown that during symptomatic primary HIV-I 
infection, the levels of infecting virions and of infected 
helper T cells are very high in the range of 1,000- 10,000 
TCIDlpJ of phase [2, 3]. 
The second phase of HI V- I infection is called the 
latency phase. During this phase, the patient undergoes a 
drastic reduction in HIV-I viremia and the amount of viral 
antigen in most but not all patients [5]. During this phase, 
the infected patient is asymptomatic and shows no sign of 
fully blown AIDS. The proportion of cells carrying HI V-J 
DNA is higher in the lymph nodes than in the peripheral 
blood [10]. HIV- l viral replication occurs throughout the 
asymptomatic phase, but the function of susceptible cells 
that are producti vely infected at any given time is low. The 
CDS+ cytotoxic T lymphocytes mediate the destruction of 
in fected HI V- l T cells [13, 16]. However, some infected 
CD4+ helper cells serve as the host or laboratory for the 
production of the HIV-I virions [\9]. Using protease 
enzymes and the retro-virus called reverse transcriptase and 
resources of the host CD4+ T-lymphocytes, the HIV virions 
are assembled into pro-virus equipped with the glycoprotein 
gpl20 and gp4l. The newly assembled HIV-I virions are 
released into the blood plasma by the process called budding. 
This rate is curtailed during the asymptomatic phase. 
The third phase of H1V- 1 dynamics is determined by 
increase in plasma HIV-l virions and down-regulation of 
the CDS+ T-lymphocytes responses. In particular, the CD4+ 
T-lymphocytes infection increases. There is also re lease of 
HIV- I virions from the reservoirs such as the lymphoid 
organs, microglial cells of the brain and other sources [1 4, 
18J. 
Many determ inistic mathematical models of HIV- I 
patho-physiodynamics have been constructed in the last few 
years. The models incorporate the HIV-I interaction with 
the Helper CD4+ T-Iymphocytes and the Cytotoxic CDS+ 
T-Iymphocytes. Such models include those by Pantaleo el 
al.[ I 0], Essunger and Perelson [4], Perelson et al. [II ], 
Kirschner and Webb [7], Wodarz et al. [ IS, 19]. There have 
been stochastic mathematical models of HIV-I dynam ics, 
such as the model by Tackwell and Le Corfec [IS}. Han and 
Perelson [6] have been involved in the construction of 
HIV-I stochastic models for the compUiation and estimation 
of HIV - I interaction coefficients. 
In this paper, new mathematical mode ls for the 
asymptotical latency phase are proposed and analyzed. In 
particular, elaborate and robust mathematical criteria will be 
derived depicting the conditions under which the latency 
period can be maintained indefinitely. 
The major contribution of the current research is the 
fonnulation of robust criteria under which the HIV-I virions 
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will be annihilated or kept under a chronic asymptomatic 
latency phase in the absence of anti-HIV-1 drug therapy. 
This paper is organized into five sections. Section 2 
provides definitions of parameters that are used in the model 
equations. Section 3 discusses the model equations and 
necessary criteria for the existence of the equilibrium points 
or disease outcomes during the latency phase. Section 4 
presents computer simulation results and associated graphs. 
Section 5 gives a summary. 
2. Parameters 
A number of parameters, constants will be used in the 
model. We define them as follow. 
XI: the number density of un-infected CD4~ helper 
T-lymphocytes per unit volume 
X2: the number density of HI V- I infected CD4+ helper 
T-lymphocytes per unit volume 
X) : the number density of HI V-I virions in the blood plasma 
per unit volume 
X4: the number densi ty of HIV-1 specific CDS+ cytotoxic 
T-lymphocytes per unit volume 
SI: rate of supply of un-infected CD4+ T4-lymphocytes 
S2: rate of supply oflatency infected CD4+ T4-lymphocytes 
S3: rate of supply of HIV- J virions from macrophage, 
monocytes, microglial cells and other lymphoid tissue 
different from T4-lymphocytes 
S4: rate of supply ofCDS+ Ts-lymphocytes from the thymus 
a" h;: constant associated with activation of lymphocytes by 
cytokine interleukin-2 (IL-2) 
a j: constant associated with HIV-l infection of CD4+ T4 
helper cells 
A the number of HI V-I virions produced per day by 
replication and budding in CD4+ T4 helper cells 
/h. : rate constant associated with replication and "budding" 
of HIV-I in syncytia CD4+ T4 helper cells per day per 
micro liter (Ill) and released into the blood plasma 
fl:, . the number of HIV-I virions produced per day by 
replication and "budding" in non-syncytia CD4+ T4 
helper cells and released into the blood plasma 
qi: constant depicting competition between infected and 
un-infected CD4~ T4 helper cells 
k;: constant depicting degradation, loss of clonogenicity or 
"death" 
e.o: constant depicting death or degradation or remova l by 
apoptosis (programmed cell death) 
Ki : constant associated with the kil ling rate of infected CD4-+ 
T4 cells by CDS+ Ts cytotoxic lymphocytes 
3. Dynamics of HIV-I during latency 
phase 
In the latency phase, the HIV -I patho-physiodynamics 
equations reduce to 
XI '" SI + olxl'e -btx, -alxlxJ -qIX'X l - klx l -elO 
Xl '" S1 +olx1x,e -b,., + a lxlx j - q1XIX1 - k1x2 - PIX] - K,x, x. -ero 
Xl == Sl + P 1X1XJ + PJXJ - a j x1x3 -k1x1-e10 
X. == S. + o. x,x.e .... ·>' - K2x1X. -k.X4 -e.o 
X,(II)==X,L for i== {1, 2,3,4} (3 .1) 
Lei 
C J '= Sup la jX ,X je- h/ X , J for j'= {J,2,4} 
I"(IL.I ~ ) 
C l = Sup [,B 2X2 X3 + P 3X3 ] 
1~ [IJ_h l (3.2) 
Where IL is the time at which the latency phase begins. 
Similarly,lp is the time at which the post latency phase of 
HIV-I dynamics commences in a patient. 
The system of differential equations (3.1) reduce to the 
following differential inequalities, for f E [ / l.o Ip]: 
1 
~ I :S S I + C I - k I X 1 - e 10 
X 2 :S S2 + C 2 - k 1 x 2 - e l O 
X J :::; S 3 + C J k JX J - e JO 
x .:::; S . +C 4 -k4X 4 -e 40 r (I, = x " X 2 (t L ) = X 2 I. 
X j (/ L ) x J I. 
X 4 (t1. ) x " 
(3.3) 
Using the Kamke comparison technique [S], the 
differential inequalities lead to the fol lowing theorem . 
Theol"em 
Lei 
(3.4) 
Consider the set 
A = kx l , X 2 ' Xl' X 4 ) E 91 ~ 10 ::;; X i < m ; } 
Then all solutions of the initial value problem (3 .1) that 
originally in int9i'+ 4 will eventually enter the set of A, such 
that the solution will be non-negative, ultimately bounded 
and remain in A for alit E 91,. 
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Proof 
The differential inequalities (3.3) can be used to oblairl 
the following expressions: 
Si+C,-e ;o -k ,1 
+ a i Oe k, X, ::;; 
where (1' ,0 E 91- and i= {I , 2 , 3, 4} 
Hence. fori = {l , 2, 3,4}, 
. S +C-e 
11m Sup Xi(t) = ' k ' iO 
, 
and 
x,(t) E Sup X;o. I I ,0 { 
S +C -e } 
A ki 
Thus the flow associated with the system (3.1) is 
dissipative, and non-negati ve if Si +C; - eiO > 0, and 
eventually enter the set A and remains trapped in A for t E 91', 
ifxiOE int9i'_4, 0 
3.1 Criteria for permanency of latency phase 
In this section, the criteria for the permanency of the 
latency phase will be derived. 
The differential equation for the HIV-J patho-
physiodynamics during the latency phase is : 
x 1(t) = SJ + P2Xl - a Jx1x 1 - k 1x 1 - e 10 
where S3 is the reflux and repopulation rate of the plasma 
HIV-J virions from the lymphoid tissue, microgial cells, 
ret icules-endothelial cells, monocyteslmacrophages and 
other sanctuaries. e30 is a constant degradation rate of HIV-l 
virions. fh. is the "budding" rate constant of HI V-I virions. 
Lot L, = Sup 
and SJ -eJo;:: O, 
then 
and 
X I (t ) 
where k is a positive constant. 
In particular, the following scenarios arise: 
(i) If kJ + a]LI-fJ2 >0 then as t ~ 00, 
S - e limSupx3 (t) = J 30 kJ + a l LI - /32 
In this case, the HIV-l virions population does not 
increase but tend to a constant gro\Vth profile. This effect 
has been demonstrated in vivo by Chun et al [ J l-
(ii) If kJ +a)~ -fJ2 < ° and then as t ~ 00 , the HIV-J 
virions population becomcs exponential with time, and the 
patient will now be in the post-latency phase of viral growth 
dynamics and will develop fully-blown AIDS disease. 
3.2 Clinically significant HIV-l disease 
outcomes during latency phase 
The clinically significant outcomes of HI V-I dynam ics 
can obtained as follow. The outcomes are called equilibrium 
points or sturdy states which are associated with the model 
equations. There are five most clinically interesting 
outcomes labeled {E,: i - 1,2,3,4, 5} . 
(i) EI .. [0, 0, 0, 0]: this represents the case in which 
uninfected CD4~ T cells, infected CD4+ T cells, HIV-J 
virions in blood plasma, and HIV-J specific CD8+ T cells 
are all destroyed. This leads to the immune system paralysis 
in which the patient dies of opportunistic bacteria or viral 
infection. This case is clinically feasible if Si - e jO =0. 
(ii) E2 = [Xl ' 0, 0, X4 ] : this represents the case in which 
infected CD4+ T cells and HIV-l virions in blood plasma are 
all destroyed. Clinical doctors working with HIV-l infected 
patients would like to achieve this outcome. This 
equilibrium point is clinically possible Wlder the following 
necessary conditions: 
(3 .5) 
(iii) E3 "'" [0, X 2' x3' 01: this depicts a cl inically worst case 
situation in which both uninfected CD4~ T cells and HIV-I 
specific CDS'" T cells are destroyed. This equilibrium point 
is clinically possible under the following necessary 
conditions: 
(3 .6) 
(iv) £4 = [XI' 0, 0, 0]: this is the most clinically desirable 
equilibrium point in which infected CD4+ T cells, plasma 
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HIV- I virions, and HIV-I specific cytotoxic CD8+ T cells 
are all annihilated. The necessary conditions for the 
existence of this equilibrium point are: 
IS) + a)xl~e - bli" - klx l - e 10 = 0 S 2 - e 20 - 0 S 3 - e 30 = 0 (3 .7) S4-e 40 =0 
(v) Es= [X I ,X2 , X3 ,X4 ]: this case can only exist if the 
equation (3.0) exhibits persistence in which all the four 
factors co-exist. The details of showing persistence in 
nonlinear systems of differential equations have been 
discussed by Nani and Freedman in [8]. 
There are other equ ilibrium points such as E[xt, X2, 0, 0], 
E [0, 0, X" '4] and many planar or axial points. These are 
clinical unfeasible and are not considered in this paper, but 
will be analyzed in a future paper. 
4. Simulation results and discussion 
In this section, investigative computer simulations are 
perfonned under specific parametric configurations. The 
model data values shown in Table I and Table 2 are 
compatible with the data values used in the literatures [4, 7, 
15, 17]. It should be noted that it is virtually impossible to 
get all values for a particular HIV-I infected patient [20]. 
The time scale used in the hypothetical simulations is 
nonnalized in years. We only present two scenarios of the 
simulations, as shown in Figure I and Figure 2. Other 
simulation results will be published in future papers. In 
Figure I, it can be observed that the HI V-I virions (X3) is 
restricted to a relatively long latency period, due to effective 
cyto lytic action of the CD8+ cytotoxic T cells (X4) . In Figure 
2, it can be seen that HIV- J virions undergo a relatively 
short latency period and then replicate rapidly in the 
presence of non-effective cytolytic action of CD8+ 
cytotoxic T cells (X4) . The difference between the two 
simulation results can be accounted for by non-zero value of 
S3 which depicts HI V- I virions released from all viral 
reservoirs [12, 17]. 
Based on the above simulation results, we have the 
following observations: 
(i) Both the un-infected CD41" T cells and HIV- J specific 
CD8+ T cells survive during the latency phase. 
(ii) The infected CD4+ T cells and the plasma HIV-I virion 
concentration are comp letely annihilated . 
(iii) The patient will be in the chronic asymptomatic HIV-l 
infection state. The disease configuration is £ 2"" [ XI ' 0, 
0, .\-4 J. 
(iv) In order for the patient to continue to be in the latency 
phase the necessary conditions (3 .5) must be 
maintained in addition to certain sufficiency conditions 
obtained by either using Liapunov functions for global 
stability or using unifonn persistence criteria (see [ 8]). 
Table I Parametric Configuration ~ 
SI - I.S /day/pi S 2 - 0.85 /day/pi S3 - 0.0 /day/pi S4 - 0.272 /day/pl 
a) = 0.009 /day/cell/pi a 2 = 0.004 /day/celVpi fJ2 = 0 virons/CD4~/day/.uI a4 = 0.0075 /day/celll.ul 
b1 = 0.00J /cell/pi b2 = 0.004/ce\llpi f3J = 50 vironS/CD4+/day b4 = O.OOI /cell/,ul 
0: 1 = O.OS/day/virion/pi 0:2= O.lIday/virioni pi 0:3 == O.0027/day/virionlpi K2 = 0.0024 /day/pi 
kl = O.OOS/day/pi k2 = O.05/day/pi k 3 = 0.000 IIday k4 = O.OOI /day/pi 
ql = 0.0045/day/pJ/cell q2 = O.OOOl /day/pi/cell e30 = 0.0001 /day e40 = 7.75 cells/day/pi 
elO = 8.8 cells/day/pi f3t = 50 virons/CD4+/day X31. = 0.01 cells/.uI X41. = 800 cells/pi 
X II. = 703 cells/pi KI = O.OOI /day/pi 
e20 = 0.005 cells/day/.uI 
X21. = 100 celis/pi 
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Table 2 Parametric Configuration P1 
SI - J.5 /day/pJ S, - 0.85 /day/pI S, - 10.5 /day/pI S4 - 0.272 /day/pl 
01 = 0.009 /day/celV,ul a2 = 0.004 /day/ccIV,ul p, - 0.025 a4 == O.OO7S /day/ceIV,u1 
hi == O.OOI/cell/pi b2 = O.004/cell/.uJ vironsJCD4+/dayl,ul b4 == 0.00 I Icell/,ul 
at = O.05/day/virionipJ a2= O. I/day/virion! pi /3; = 51 virons/CD4+/day Kl = 0.0024 /day/pJ 
kl = O.OOS/day/J.d k2 = O.OS/day/pi a] = O.027/day/virionl,ul k4 = O.08/dayl,ul 
q1 =O.0045/day/,uVceli q2 = O.OOOl /day/,ulIcel l kJ = O.OOO I/day e 40 = 10.75 cells/day/.uJ 
CIO = 8.8 cells/day/pi PI = 51 vironsJCD4+/day eJO = 0.000 I Iday X4L = 800 cells!,uI 
XlL = 703 cel ls/pI Kl = O.OO I /day/pi Xn = 5.5 cells/pi 
ezo '" 0.005 celts/day/pi 
Xu = 200 cells/pI 
X, x, 
10000 300 
8000 250 
6000 200 
/" 150 4000 / JOO 2000 50 
0 0 
0 , 4 6 8 JO 0 , 4 6 8 JO 
,3 X, 
JO 10000 
8 8000 
6 6000 ....... 
4 4000 / / , 2000 
0 0 
-, 0 0 2 4 6 8 JO 
Figure 1 Simulation results using parametric configuration PI 
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XI x, 
99Q 390 
79Q 
'"' 
290 U 5911 190 
J9Q 
1911 90 
-10 
-10 
0 2 4 6 8 10 0 2 4 6 8 10 
X3 X 4 
3500 lOOOOQ 
3000 80000 
2500 / I 200Q 60000 / 1500 40000 
1000 
./ 
500 20000 
0 0 
0 2 4 6 8 10 0 2 4 6 8 10 
Figure 2 Simulation results using parametric configuration P. 
5. Summarizing remarks 
In this paper, we have presented a novel and robust 
approach to the study of HIY-I dynamics during the latency 
phase. The special contribution of this model includes an 
explicit role of source tenns SI> S2, S3, 54, which depict 
recruitment from the thymus gland and the HIY-l viral 
reservoirs [14]. Clinically relevant activation functions 
describing the action of IL-2 on the T cells are also included 
in the model equations. The clinical outcomes are clearly 
exhibited together with the associated criteria for existence. 
In particular, the simulation results depict the scenario of 
chronic asymptomatic HIV-I infection during latency phase 
in which the infected CD4+ T cells and the plasma, viremia 
are annihilated. The results, to some extent, agree with and 
add more details to the ones obtained in earlier HIV-I 
research [4, 11 , 14, 16, 19]. 
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